Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Alberta Vascular Risk Reduction Community Pharmacy Project: RxEACH

NCT01979471 is registered in ClinicalTrials.gov with University of Alberta as lead sponsor.

NCT NCT01979471
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01979471 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Alberta Vascular Risk Reduction Community Pharmacy Project: RxEACH
Lead sponsor
University of Alberta
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2014
Completion date
December 31, 2015
Enrollment
723 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease, diabetes, established atherosclerotic vascular disease, framingham risk score more than 20 percent